Seeing Is Believing
Currently out of the existing stock ratings of Asthika Goonewardene, 108 are a BUY (85.04%), 18 are a HOLD (14.17%), 1 are a SELL (0.79%).
Analyst Asthika Goonewardene, currently employed at TRUIST, carries an average stock price target met ratio of 36.32% that have a potential upside of 33.79% achieved within 108 days.
Asthika Goonewardene’s has documented 249 price targets and ratings displayed on 23 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on EXEL, Exelixis at 23-Jun-2025.
Analyst best performing recommendations are on IMGN (IMMUNOGEN).
The best stock recommendation documented was for IOVA (IOVANCE BIOTHERAPEUTICS) at 12/27/2023. The price target of $17 was fulfilled within 62 days with a profit of $9.77 (135.13%) receiving and performance score of 21.8.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$10
$8.82 (747.46%)
1 months 14 days ago
(14-May-2025)
2/10 (20%)
$9.05 (952.63%)
94
Buy
$9
$7.82 (662.71%)
$10
1 months 14 days ago
(14-May-2025)
0/3 (0%)
$8.05 (847.37%)
Buy
$7
$5.82 (493.22%)
$9
1 months 14 days ago
(14-May-2025)
2/9 (22.22%)
$6.05 (636.84%)
3
Buy
$8
$6.82 (577.97%)
$9
3 months 9 days ago
(19-Mar-2025)
0/10 (0%)
$6.31 (373.37%)
Buy
$14
$12.82 (1086.44%)
3 months 14 days ago
(14-Mar-2025)
1/3 (33.33%)
$12.06 (621.65%)
192
Which stock is Asthika Goonewardene is most bullish on?
Which stock is Asthika Goonewardene is most reserved on?
What Year was the first public recommendation made by Asthika Goonewardene?